Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Clinical trial NCT00729612 · COMPLETED
Trial details
- NCT number
- NCT00729612
- Sponsor
- Greg Otterson
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-14
- Primary completion
- 2011-12-16
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.